Vandiepenbeeck Marc, VP & President of EMEALA, has demonstrated a clear pattern of insider activity in Johnson Controls International (JCI) shares, with a notable shift from buying to selling in recent years. Between 2024 and early 2026, Marc executed 25 transactions exclusively in JCI, with a strong historical buy bias—$7.15 million in total purchases, including a single $4.99 million acquisition on March 12, 2025, and a $1.04 million buy on February 1, 2024. However, the recent trend has reversed sharply, with 12 sales since 2024 totaling $2.13 million, including multiple six-figure dispositions. The largest recent sales occurred on December 8, 2025 ($775,885 and $35,299) and February 1, 2026 ($379,962), alongside smaller but consistent monthly sales throughout 2024, typically ranging between $10,000 and $13,000 per transaction.
The transactions suggest a transition from accumulation to gradual divestment, with Marc’s selling activity accelerating in late 2025. While earlier filings indicate a significant long-term position built through acquisitions—particularly the March 2025 purchase—the recent sales, often coded as "F" (tax liability or payment for exercise) and "S" (open market sale), point to a reduction in exposure. The absence of any buys since early 2025 contrasts with the steady liquidation of shares, though the retained position remains substantial given the scale of prior purchases. The activity is confined solely to JCI, reflecting a concentrated rather than diversified insider trading pattern.
AI-assisted summary